Drugs / Kelo-cort™
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01861119 | Apr 2013 → Feb 2014 | reactive cutaneous fibrous lesion | CHA University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kelo-cort | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01861119 ↗ |
| Known as | Silicone gel | “Silicone gel (Kelo-cort™; Advanced Bio-Technologies, Silverdale, WA, USA) From the day of suture removal, the treatment was applied three times daily for 3 months.” NCT01861119 ↗ |